REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/08/2026
Back to search
Official data from USPTO
LYPTIMZ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/09/2026
Trademark type
Word
Nice classes
5
Filing date
09/03/2020
Registration date
06/08/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2021
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
32 publications found
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/29/2021
FIMP
FINAL DISPOSITION PROCESSED
09/29/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/22/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2021
RFNT
REFUSAL PROCESSED BY IB
01/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/05/2021
RFRR
REFUSAL PROCESSED BY MPU
01/05/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/16/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/16/2020
CNRT
NON-FINAL ACTION WRITTEN
12/15/2020
DOCK
ASSIGNED TO EXAMINER
12/14/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/31/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/27/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/26/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/22/2020
Continuous trademark protection
Get notified about every new filing that threatens LYPTIMZ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.